Adhering to current clinical guidance supports evidence-based assessment, informs decision-making, and helps limit or prevent organ damage in patients living with vasculitis. Ongoing review of recommendations and guidance enables clinicians to improve evaluation and management, which supports better patient outcomes.
Today's rundown features guidelines focusing on forms of vasculitis from North American and international societies including the American College of Rheumatology (ACR), British Society for Rheumatology (BSR), and others.
The Latest Vasculitis Clinical Guidelines
- ANCA-Associated Vasculitis
- British Society for Rheumatology (BSR), published June 2025
- Managing People with Behçet’s
- British Association of Dermatologists (BAD) / British Society for Rheumatology (BSR), September 2024
- Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
- Kidney Disease Improving Global Outcomes (KDIGO), published February 2024
- Management of ANCA-Associated Vasculitis
- European League Against Rheumatism (EULAR), published March 2023
- Management of Kawasaki Disease
- American College of Rheumatology (ACR), March 2022
- Management of Polyarteritis Nodosa
- American College of Rheumatology (ACR), published July 2021
- Management of Giant Cell Arteries and Takayasu Arteritis
- American College of Rheumatology (ACR), published July 2021
- Treatment and Management of ANCA-Associated Vasculitis
- American College of Rheumatology (ACR), published July 2021
Check out other clinical guidelines and sign up for alerts to stay informed on the latest published guidelines and insights.
Copyright © 2026 Guideline Central, all rights reserved.